Related Experiment Videos
Malignant biliary strictures. Diagnosis and management
Ibrahim A Al-Mofleh1, Rashed S Al-Rashed, Saleh M Al-Amri
1Gastroenterology Division, Department of Medicine (59), King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia.
Saudi Medical Journal
|January 8, 2004
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is optimal for diagnosing and palliating malignant biliary strictures (MBS). This study found ERCP offered better survival outcomes compared to other methods for non-resectable tumors.
Area of Science:
- Gastroenterology
- Oncology
- Interventional Radiology
Background:
- Malignant biliary strictures (MBS) pose significant diagnostic and management challenges.
- Understanding local patterns of MBS is crucial for optimizing patient care.
Purpose of the Study:
- To determine the causes, diagnostic methods, and management strategies for malignant biliary strictures (MBS).
- To compare institutional findings with international studies on MBS.
Main Methods:
- A retrospective review of 1000 patient files undergoing endoscopic retrograde cholangiopancreatography (ERCP) for MBS.
- Analysis of clinical data, laboratory results, diagnostic techniques, and treatment outcomes.
Main Results:
- MBS were identified in 72 patients (7.2%), with cholangiocarcinoma and pancreatic adenocarcinoma being the most common causes.
- ERCP was the primary diagnostic tool (93%).
- Endoscopic palliation (77.8%) showed superior mean survival (6.9 months) compared to percutaneous drainage (4.27 months) and surgery (3.67 months).
Conclusions:
- ERCP is the preferred method for diagnosing and palliating non-resectable malignant biliary strictures (MBS).
- Endoscopic management offers improved survival outcomes.